Dermatology

This site is intended for healthcare professionals only

Medical Jobs
Medical Matrimony
MD Brand Connect
Corona Updates

Medical News
Health news
Medical Guidelines
AYUSH
State News
Medical Education
Industry

This site is intended for healthcare professionals only

Sign In Register

Sign inRegister

Home
Medical news
Health news
Medical Guidelines
Medical Education
Industry
Case of the Day
Editorial

Ruchika joined Medical Dialogue an Desk Editor for the Business Section in 2019. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home
ruchika

Articles By : ruchika

Reduced GST rates on COVID drugs extended till December

Reduced GST rates on COVID drugs extended till December

ruchika18 Sep 2021 12:14 PM GMT

Lucknow: The GST Council on Friday extended concessional tax rates on COVID-19 medicines, cut tax on cancer drugs and waived GST on import of highly ex...

Bharat Biotech awaits WHO feedback for Covaxin emergency use listing

Bharat Biotech awaits WHO feedback for Covaxin emergency use listing

ruchika18 Sep 2021 7:24 AM GMT

New Delhi: Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its CO...

COVID vaccine protection wanes, makes case for booster, says Moderna

COVID vaccine protection wanes, makes case for booster, says Moderna

ruchika18 Sep 2021 5:33 AM GMT

Chicago: New data from Moderna Inc's large Covid-19 vaccine trial shows that the protection it offers declines over time, supporting the case for boost...

Takeda Pharma gets USFDA nod for cancer treatment EXKIVITY

Takeda Pharma gets USFDA nod for cancer treatment EXKIVITY

ruchika18 Sep 2021 4:30 AM GMT

Osaka: Drugmaker, Takeda Pharmaceutical Company Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has...

LifeCell gets DCGI approval for clinical trial of Mesocel to treat COVID patients

LifeCell gets DCGI approval for clinical trial of Mesocel to treat COVID patients

ruchika17 Sep 2021 10:55 AM GMT

New Delhi: Stem cell bank LifeCell on Thursday said it has received approval from the Drug Controller General of India (DCGI) for a clinical trial of M...

Glenmark concludes PMS study on Favipiravir in COVID patients

Glenmark concludes PMS study on Favipiravir in COVID patients

ruchika17 Sep 2021 7:33 AM GMT

Mumbai: Drugmaker, Glenmark Pharmaceuticals, has recently announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipi...

Biocon Biologics, Serum Institute Life Sciences enter strategic alliance

Biocon Biologics, Serum Institute Life Sciences enter strategic alliance

ruchika17 Sep 2021 7:18 AM GMT

Bengaluru: Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum ...

Amalgamation scheme of Lincoln Parenteral, Lincoln Pharma approved by NCLT

Amalgamation scheme of Lincoln Parenteral, Lincoln Pharma approved by NCLT

ruchika17 Sep 2021 3:30 AM GMT

Ahmedabad: National Company Law Tribunal, Ahmedabad Bench, (NCLT) has approved the scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharm...

Decision on Zydus Cadila Covid-19 vaccine prices soon: Dr VK Paul

Decision on Zydus Cadila Covid-19 vaccine prices soon: Dr VK Paul

ruchika16 Sep 2021 7:37 AM GMT

ZyCoV-D is the world's first plasmid DNA vaccine for Covid-19.

Lupin unveils generic Duexis tablets in US

Lupin unveils generic Duexis tablets in US

ruchika16 Sep 2021 6:01 AM GMT

Mumbai: Global pharma major, Lupin Limited, has recently announced the launch of the authorized generic version of Duexis (ibuprofen and famotidine) Ta...

ENTOD Pharma launches super speciality surgical division HyTek

ENTOD Pharma launches super speciality surgical division HyTek

ruchika16 Sep 2021 5:30 AM GMT

New Delhi: ENTOD Pharmaceuticals has recently announced that the company has launched their super-specialty ophthalmic surgical division, 'HyTek' ...

BDR Pharma unveils generic cancer drug Cabozantinib in India

BDR Pharma unveils generic cancer drug Cabozantinib in India

ruchika15 Sep 2021 7:11 AM GMT

New Delhi: Drug firm BDR Pharmaceuticals on Tuesday said it has launched generic Cabozantinib, used for the treatment of various types of cancer, and w...

© 2019 All Rights Reserved.

Powered By: Hocalwire

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok

X

Advertisement

X

X